Servier Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Suresnes France (1954)

Organization Overview

First Clinical Trial
2000
NCT00122811
First Marketed Drug
2018
ivosidenib (tibsovo)
First NDA Approval
2018
calaspargase pegol
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ADIR, a Servier Group company | Biogaran | Institut de Recherches Internationales Servier | Institut de Recherches Internationales Servier (I.R.I.S.) | Les Laboratoires Servier (LLS) | Les Laboratoires Servier (L.L.S), Russia | Servier | SERVIER | Servier Affaires Médicales | Servier Laboratories (Australia) Pty Ltd | Servier Pharmaceuticals, LLC | SERVIER PHARMA LLC